Wilcox, Lauren |
NCT06340451: Study to Assess the Efficacy and Safety of Iovera®° System in Subjects with Upper Extremity Spasticity |
|
|
| Recruiting | 3 | 132 | US | iovera° system, sham iovera° system treatment | Pacira Pharmaceuticals, Inc | Spasticity, Cerebral or Spinal Condition | 04/25 | 04/25 | | |
NCT05820451: Impella Real-World Surveillance of Patients Using Sodium Bicarbonate |
|
|
| Completed | N/A | 312 | NA | Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution, Impella RP with Sodium Bicarbonate used as purge solution | Abiomed Inc. | Cardiogenic Shock, High Risk PCI | 02/24 | 02/24 | | |
Sowa, Gwendolyn |
| Completed | 4 | 1014 | US | Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta | University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Chronic Low-back Pain | 07/24 | 10/24 | | |
| Completed | 2 | 41 | US | Metformin, Glucophage, Glucophage XR, Metformin Extended Release, Metformin ER, Placebo | Gwendolyn Sowa | Low Back Pain | 12/23 | 12/23 | | |
| Recruiting | N/A | 170 | US | There is no intervention. It is a phenotyping study only | University of Pittsburgh, National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH) | Chronic Low-back Pain, Myofascial Pain | 12/25 | 12/27 | | |